CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Open-market sale Chief Executive Officer sold 25,135 shares at $4.80 ($120,618)
- 4 Open-market sale Chief Financial Officer sold 6,920 shares at $4.80 ($33,208)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 41,250 shares (grant or award)
- 4 Grant or award Director acquired 41,250 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Financial Officer sold 5,716 shares at $6.92 ($39,562)
- 4 Open-market sale Chief Executive Officer sold 18,837 shares at $6.92 ($130,386)
Page 11 of 32 · 631 filings